Mahana Therapeutics Signs Agreement with Consumer Health Division of Bayer to Commercialize DTx
- DHV-NET
- Aug 22, 2023
- 1 min read
Partnership brings together Mahana’s expertise in digital therapeutic development with Bayer’s stated interest to deliver products that enable people to take greater control of their own personal health through world-leading digital solutions.
